Prior long response to androgen deprivation predicts response to next-generation androgen receptor axis targeted drugs in castration resistant prostate cancer-Reference-Cited by-同舟云学术

Prior long response to androgen deprivation predicts response to next-generation androgen receptor axis targeted drugs in castration resistant prostate cancer

Published:2015-09 Issue:14 Volume:51 Page:1946-1952
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Loriot Yohann,Eymard Jean-Christophe,Patrikidou Anna,Ileana Ecaterina,Massard Christophe,Albiges Laurence,Di Palma Mario,Escudier Bernard,Fizazi Karim

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference32 articles.

1. Prostate cancer: ESMO consensus conference guidelines 2012;Horwich;Ann Oncol,2013

2. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate;Huggins;J Urol,2002

3. Targeting continued androgen receptor signaling in prostate cancer;Massard;Clin Cancer Res,2011

4. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N Eng J Med,2011

5. Final overall survival (OS) analysis of COU-AA-301, a phase 3 study of abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) pretreated with docetaxel;Fizazi;Lancet Oncol,2012

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer;European Urology;2024-08

2. Outcomes and patterns of use of Radium-223 in metastatic castration-resistant prostate cancer;Frontiers in Oncology;2024-05-07

3. Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer care;Prostate Cancer and Prostatic Diseases;2024-02-12

4. Real-World Treatment Patterns Among French Patients With Metastatic Castration-Resistant Prostate Cancer Under Abiraterone or Enzalutamide;Clinical Genitourinary Cancer;2023-10

5. Clinical characteristics of patients with metastatic castration-resistant prostate cancer after treatment with combined androgen blockade;BMC Urology;2023-04-28